149 related articles for article (PubMed ID: 228444)
1. The effects of dextran sulfate, heparin and PGE1 on adenylate cyclase activity and aggregation of human platelets.
Reches A; Eldor A; Salomon Y
Thromb Res; 1979; 16(1-2):107-16. PubMed ID: 228444
[No Abstract] [Full Text] [Related]
2. Heparin inhibits PGE1-sensitive adenylate cyclase and antagonizes PGE1 antiaggregating effect in human platelets.
Reches A; Eldor A; Salomon Y
J Lab Clin Med; 1979 Apr; 93(4):638-44. PubMed ID: 429861
[TBL] [Abstract][Full Text] [Related]
3. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
[No Abstract] [Full Text] [Related]
4. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
Macfarlane DE; Mills DC; Srivastava PC
Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146
[No Abstract] [Full Text] [Related]
5. Inhibition of prostaglandin E1-responsive platelet adenylate cyclase by heparin: a study of the mechanism of inhibition and its relevance to platelet aggregation.
Amirrasooli H; Mac Neil S; Tomlinson S
Br J Pharmacol; 1981 Jul; 73(3):639-47. PubMed ID: 7248663
[TBL] [Abstract][Full Text] [Related]
6. Modulation of human platelet adenylate cyclase by prostacyclin (PGX).
Gorman RR; Bunting S; Miller OV
Prostaglandins; 1977 Mar; 13(3):377-88. PubMed ID: 191876
[TBL] [Abstract][Full Text] [Related]
7. Roles of cyclic nucleotides in platelet function.
Haslam RJ
Ciba Found Symp; 1975; 35():121-51. PubMed ID: 179765
[No Abstract] [Full Text] [Related]
8. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
9. Modulation of adenylate cyclase activity by sulfated glycosaminoglycans. II. Effects of mucopolysaccharides and dextran sulfate on the activity of adenylate cyclase derived from various tissues.
Amsterdam A; Reches A; Amir Y; Mintz Y; Salomon Y
Biochim Biophys Acta; 1978 Dec; 544(2):273-83. PubMed ID: 152657
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
Best LC; Martin TJ; Russell RG; Preston FE
Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
[No Abstract] [Full Text] [Related]
11. Inhibition of platelet adenylate cyclase by ADP.
Mellwig KP; Jakobs KH
Thromb Res; 1980 Apr 1-15; 18(1-2):7-17. PubMed ID: 6250246
[No Abstract] [Full Text] [Related]
12. Inhibition of platelet aggregation by 6-keto-PGE1; lack of an effect on cyclic GMP levels.
Pontecorvo EG; Myers CB; Lippton HL; Kadowitz PJ
Prostaglandins Med; 1981 May; 6(5):473-83. PubMed ID: 6267636
[TBL] [Abstract][Full Text] [Related]
13. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
Clare KA; Scrutton MC; Thompson NT
Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472
[TBL] [Abstract][Full Text] [Related]
14. 5'-N-ethylcarboxamidoadenosine: a potent inhibitor of human platelet aggregation.
Cusack NJ; Hourani SM
Br J Pharmacol; 1981 Mar; 72(3):443-7. PubMed ID: 7260485
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives.
Harris DN; Asaad MM; Phillips MB; Goldenberg HJ; Antonaccio MJ
J Cyclic Nucleotide Res; 1979; 5(2):125-34. PubMed ID: 221552
[TBL] [Abstract][Full Text] [Related]
16. Human platelet aggregation and cAMP system--cAMP level, adenyl cyclase, phosphodiesterase.
Wang TY; Hussey CV; Sasse EA; Fobian JE
Ann Clin Lab Sci; 1978; 8(5):403-12. PubMed ID: 213009
[TBL] [Abstract][Full Text] [Related]
17. Heparin and dextran sulfate antagonize PGI2 inhibition of platelet aggregation.
Eldor A; Weksler BB
Thromb Res; 1979; 16(5-6):617-28. PubMed ID: 392805
[No Abstract] [Full Text] [Related]
18. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
[TBL] [Abstract][Full Text] [Related]
19. Dextran 40 reduces heparin-mediated platelet aggregation.
Sobel M; Adelman B; Greenfield LJ
J Surg Res; 1986 Apr; 40(4):382-7. PubMed ID: 2422443
[TBL] [Abstract][Full Text] [Related]
20. Relation between the inhibition of aggregation and the concentration of cAMP in human and rat platelets.
Michel H; Caen JP; Born GV; Miller R; D'Auriac GA; Meyer P
Br J Haematol; 1976 May; 33(1):27-38. PubMed ID: 178342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]